4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-23-003052
Chief Operating Officer sold 3,125 shares at an average $8.55 ($26,733)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ADAMS R MARK Chief Operating Officer | 2023-01-09 | Sale | −995 | $8.50 | $8,458 | 115,648 | D: show line 1 in the form |
| ADAMS R MARK Chief Operating Officer | 2023-01-10 | Sale | −2,130 | $8.58 | $18,275 | 113,518 | D: show line 2 in the form |
| Open-market sales · 3,125 sh · avg $8.55 · $26,733 | |||||||
Loading xslF345X03/doc4.xml…